TANKE BIOSCIENCES CORPORATION Inactive Instrument
Tanke Biosciences Corporation Share Price Other OTC
Equities
TNBI
US87583Y1073
Fishing & Farming
| Sales 2021 | - | Sales 2022 | - | Capitalization | 1.35M 112M |
|---|---|---|---|---|---|
| Net income 2021 | - 0 | Net income 2022 | - 0 | EV / Sales 2021 | - |
| Net cash position 2021 | 39.68K 3.31M | Net Debt 2022 | 45.73K 3.82M | EV / Sales 2022 | - |
| P/E ratio 2021 |
-21.5
x | P/E ratio 2022 |
-12.9
x | Employees | - |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 23.04% |
More Fundamentals
* Assessed data
More news
| Managers | Title | Age | Since |
|---|---|---|---|
Stephen Mills
CEO | Chief Executive Officer | - | 22/21/22 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Stephen Mills
CEO | Chief Executive Officer | - | 22/21/22 |
Tanke BioSciences Corporation is an animal nutrition and feed additive provider in China, through Guangzhou Tanke Industry Co., Ltd. (Tanke). The Companyâs products include organic trace mineral additives, functional regulation additives, feed acidifiers, flavor enhancers and herbal medicinal additives. The Company operates in four segments: organic trace mineral additives, functional regulation additives, herbal medicinal additives and other. The Company conducts its business through its subsidiaries, principally its wholly owned subsidiary China Flying Development Limited (China Flying) and its wholly owned subsidiary Guangzhou Kanghui Agricultural Technology Co., Ltd. Its products address market categories within Chinaâs animal feed additive industry, including organic trace mineral additives, feed acidifiers, seasonings and flavor enhancers, and herbal medicinal additives.
Sector
Fishing & Farming
| 1st Jan change | Capi. | |
|---|---|---|
| +11.65% | 11.43B | |
| -0.21% | 5.77B | |
| -3.06% | 4.14B | |
| -21.14% | 2.58B | |
| -4.34% | 1.75B | |
| -23.47% | 1.11B | |
| -19.36% | 882M | |
| -16.59% | 865M | |
| +29.65% | 855M |
